Results 111 to 120 of about 3,996,555 (297)

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma

Cancer Management and Research, 2019
Changhui Li,1 Jindong Guo,2 Lei Zhao,2 Fang Hu,1 Wei Nie,1 Huimin Wang,1 Xiaoxuan Zheng,1 Yinchen Shen,1 Ping Gu,1 Yujun Zhang,1 Xueyan Zhang11Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030 ...
Li C, Guo J, Zhao L, Hu F, Nie W, Wang H, Zheng X, Shen Y, Gu P, Zhang Y, Zhang X   +10 more
doaj  

Conhecimento actual sobre complicações major após irradiação cerebral total ou radiocirurgia.

Acta Médica Portuguesa, 2010
Brain radiotherapy aims at controlling the pathological lesion(s) as well as avoiding damaging critical structures. However, side effects may occur. Neurocognitive function is often involved impairing quality of life.
Fátima Amaral
doaj   +1 more source

Whole-brain DTI parameters.

, 2017
Whole-brain DTI parameters.
Raúl Tudela (153860), Xavier López-Gil (3694456), Emma Muñoz-Moreno (185345), Guadalupe Soria (153838)   +3 more
core   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Whole-liver radiotherapy for diffuse liver metastases improves liver enzymes and related factors

, 2019
Whole-liver radiotherapy for diffuse liver metastases improves liver enzymes and related ...
Katsuyuki Karasawa (6181457), Keiji Nihei (6181454), Yosuke Osawa (582754), Takuya Shimizuguchi (6181448), Hiroaki Ogawa (6181451), Kei Ito (151948)   +5 more
core   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy

BMEMat, EarlyView.
Engineered bacteria serve as smart, living therapeutics that target tumors, deliver drugs, and remodel immunosuppressive microenvironments. This review highlights their potential to potentiate immunotherapy, radiotherapy, and chemotherapy, offering a promising paradigm for precise and synergistic cancer treatment. Abstract The dynamic interplay between
Haonan Shen, Weichen Zhang, Gaoli Niu, Li Wang, Ruiyan Li, Yueyue Fan, Feixue Lu, Lingling Xu, Xiaoyuan Ji, Yong Kang   +9 more
wiley   +1 more source

Long‐Term Prognosis, Residual Recurrence Risk, and Postoperative Management After Pathological Complete Response in Rectal Cancer

Cancer Nexus, EarlyView.
This graphical abstract summarizes the post‐pCR clinical pathway in locally advanced rectal cancer. After neoadjuvant radiotherapy and systemic therapy followed by surgery, patients achieving pCR (ypT0N0) generally have durable disease control, although residual risks of local and distant recurrence remain. Risk assessment, guideline‐based surveillance,
Jia‐ang Wang, Yingjiang Ye, Zhidong Gao, Sen Hou   +3 more
wiley   +1 more source

Brain Atrophy and Leukoencephalopathy Following Tarlatamab: Case Report

Respirology Case Reports
We describe the case of a 74‐year‐old female diagnosed with extensive‐stage small cell lung cancer. Initially, she received carboplatin, etoposide and atezolizumab, followed by amrubicin as second‐line treatment and nogitecan as third‐line treatment ...
Kiriko Onishi, Toki Kitano, Yusuke Fujioka, Moeko Ota, Fumie Onishi, Kohei Miyake, Hisaaki Tanaka, Nobukazu Fujimoto   +7 more
doaj   +1 more source

Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment

Rare Tumors, 2012
We present the case of a 52 years old woman who developed multiple brain metastasis after cystectomy with anterior exenteration and chemotherapy. She received whole-brain radiotherapy with 20 gray in 5 sessions.
Daniel Taussky, Pierre I. Karakiewicz, Mathieu Latour, Normand Blais   +3 more
doaj   +1 more source